Covid19, the partnership between Kedrion and Columbia University Medical Center
Interview to Dr.Steve Spitalnik
Kedrion Biopharma
L’accordo tra Kedrion e Columbia University Medical Center contro Covid19.
Intervista al Dr. Steve Spitalnik
Kedrion Biopharma and the plasma-derived therapy for Covid-19
The interview with Paolo Marcucci
Kedrion Biopharma e la terapia al plasma anti Covid-19
L’intervista con il CEO Paolo Marcucci